Policy responses and statements

Name of organisation:

Medicines and Healthcare Products Regulatory Agency (MHRA)

Name of policy document:

MLX 380 - European Commission’s proposal for a Clinical Trials Regulation

Deadline for response:

31 December 2012

Background: The Medicines and Healthcare products Agency (MHRA) is consulting on the European Commission’s proposal for a Clinical Trials Regulation. The Government is committed to ensuring that the European Union (EU) regulatory framework for clinical trials does not create unnecessary burdens on researchers and makes the EU an attractive place to conduct clinical trials. We are interested to hear the views from interested parties on the Commission’s proposal.

Download MLX 380 - European Commission’s proposal for a Clinical Trials Regulation RESPONSE as a .pdf

Copies of this response are available from:

Lesley Lockhart,
Royal College of Physicians of Edinburgh,
9 Queen Street,
Edinburgh,
EH2 1JQ.

Tel: 0131 225 7324 ext 608
Fax: 0131 220 3939

[20 December 2012]